Analysts Set AnaptysBio, Inc. (NASDAQ:ANAB) Target Price at $46.38
AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price objective among […]
More Stories
Icon Wealth Advisors LLC Has $44,000 Holdings in The Coca-Cola Company (NYSE:KO)
Icon Wealth Advisors LLC decreased its stake in shares of The Coca-Cola Company (NYSE:KO – Free Report) by 96.2% during...
Icon Wealth Advisors LLC Sells 1,764 Shares of Fiserv, Inc. (NYSE:FI)
Icon Wealth Advisors LLC lessened its stake in Fiserv, Inc. (NYSE:FI – Free Report) by 88.5% in the 3rd quarter,...
Icon Wealth Advisors LLC Has $85,000 Holdings in iShares TIPS Bond ETF (NYSEARCA:TIP)
Icon Wealth Advisors LLC lowered its position in iShares TIPS Bond ETF (NYSEARCA:TIP – Free Report) by 91.9% in the...
Kewaunee Scientific (NASDAQ:KEQU) Cut to “Hold” at StockNews.com
StockNews.com downgraded shares of Kewaunee Scientific (NASDAQ:KEQU – Free Report) from a buy rating to a hold rating in a...
Insider Buying: Nine Energy Service, Inc. (NYSE:NINE) Major Shareholder Acquires $517,650.00 in Stock
Nine Energy Service, Inc. (NYSE:NINE – Get Free Report) major shareholder William Monroe purchased 435,000 shares of Nine Energy Service...
PC Connection, Inc. (NASDAQ:CNXN) Director Sells $350,000.00 in Stock
PC Connection, Inc. (NASDAQ:CNXN – Get Free Report) Director Negrini David Beffa sold 5,000 shares of the business’s stock in...